Viatris: Peers

The FY2025 (Dec) proxy of Viatris names 15 peer companies for pay. Among Viatris and these peers, CEO pay was 7th highest of 8 and total shareholder return was 7th highest of 8.

7th highest of 8in Viatris and its pay peers, FY2025 (Dec) by CEO pay:

$7.3M$28.4M

7th highest of 8in Viatris and its pay peers, FY2025 (Dec) by total shareholder return:

$80$255

Pay peer group, FY2025 (Dec) proxy

Gilead Sciences
Pfizer
Amgen
Abbott Laboratories
Bristol Myers Squibb
Zoetis
Regeneron Pharmaceuticals
Bausch Health Companies Inc.Not disclosedNot disclosed
Baxter InternationalNot disclosedNot disclosed
BiogenNot disclosedNot disclosed
Novartis AGNot disclosedNot disclosed
Organon & Co.Not disclosedNot disclosed
SandozNot disclosedNot disclosed
Sanofi S.A.Not disclosedNot disclosed
Teva Pharmaceutical LimitedNot disclosedNot disclosed
15 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

S&P 500 Pharmaceutical Index (index)Not disclosedNot disclosed
1 company

Changes by year

FY2025 (Dec) proxy

  • AddedSandozpay peer groupdue to its market capitalization and added Sandoz as a new member of the peer group
  • RemovedEli Lilly & Copay peer groupdue to its market capitalization and added Sandoz as a new member of the peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.